Milestone Historical Cash Flow

MIST Stock  USD 1.63  0.12  6.86%   
Analysis of Milestone Pharmaceuticals cash flow over time is an excellent tool to project Milestone Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 0.0 or Stock Based Compensation of 11.5 M as it is a great indicator of Milestone Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Milestone Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Pharmaceuticals is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

About Milestone Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Milestone balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Milestone's non-liquid assets can be easily converted into cash.

Milestone Pharmaceuticals Cash Flow Chart

At this time, Milestone Pharmaceuticals' Change To Inventory is comparatively stable compared to the past year. Change In Cash is likely to gain to about 5.8 M in 2025, whereas Free Cash Flow is likely to drop (44 M) in 2025.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most accounts from Milestone Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Milestone Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.At this time, Milestone Pharmaceuticals' Change To Inventory is comparatively stable compared to the past year. Change In Cash is likely to gain to about 5.8 M in 2025, whereas Free Cash Flow is likely to drop (44 M) in 2025.

Milestone Pharmaceuticals cash flow statement Correlations

0.070.42-0.670.150.060.1-0.50.160.5-0.080.260.51-0.660.7-0.340.7-0.74-0.76-0.76
0.070.77-0.140.230.76-0.2-0.15-0.290.30.720.150.52-0.080.6-0.080.10.080.070.07
0.420.77-0.330.340.79-0.52-0.38-0.330.120.450.280.41-0.320.66-0.290.37-0.25-0.24-0.24
-0.67-0.14-0.33-0.790.010.310.910.33-0.78-0.47-0.860.010.99-0.360.85-0.970.910.950.95
0.150.230.34-0.790.1-0.71-0.87-0.720.530.690.99-0.42-0.790.02-0.950.76-0.63-0.66-0.66
0.060.760.790.010.1-0.46-0.160.05-0.180.55-0.010.26-0.010.66-0.020.10.160.180.18
0.1-0.2-0.520.31-0.71-0.460.590.580.18-0.47-0.610.570.380.010.66-0.40.230.20.21
-0.5-0.15-0.380.91-0.87-0.160.590.38-0.56-0.56-0.90.250.93-0.340.94-0.940.840.820.82
0.16-0.29-0.330.33-0.720.050.580.38-0.28-0.4-0.670.290.310.290.6-0.230.240.260.26
0.50.30.12-0.780.53-0.180.18-0.56-0.280.490.620.32-0.70.3-0.520.65-0.66-0.71-0.71
-0.080.720.45-0.470.690.55-0.47-0.56-0.40.490.62-0.06-0.450.3-0.530.44-0.18-0.21-0.21
0.260.150.28-0.860.99-0.01-0.61-0.9-0.670.620.62-0.37-0.860.04-0.970.83-0.73-0.76-0.76
0.510.520.410.01-0.420.260.570.250.290.32-0.06-0.370.090.650.42-0.060.0-0.03-0.02
-0.66-0.08-0.320.99-0.79-0.010.380.930.31-0.7-0.45-0.860.09-0.350.88-0.990.910.950.95
0.70.60.66-0.360.020.660.01-0.340.290.30.30.040.65-0.35-0.120.43-0.26-0.27-0.27
-0.34-0.08-0.290.85-0.95-0.020.660.940.6-0.52-0.53-0.970.420.88-0.12-0.860.740.760.76
0.70.10.37-0.970.760.1-0.4-0.94-0.230.650.440.83-0.06-0.990.43-0.86-0.91-0.93-0.93
-0.740.08-0.250.91-0.630.160.230.840.24-0.66-0.18-0.730.00.91-0.260.74-0.910.960.97
-0.760.07-0.240.95-0.660.180.20.820.26-0.71-0.21-0.76-0.030.95-0.270.76-0.930.961.0
-0.760.07-0.240.95-0.660.180.210.820.26-0.71-0.21-0.76-0.020.95-0.270.76-0.930.971.0
Click cells to compare fundamentals

Milestone Pharmaceuticals Account Relationship Matchups

Milestone Pharmaceuticals cash flow statement Accounts

202020212022202320242025 (projected)
Sale Purchase Of Stock80.5M85.4M48.5M121K108.9K103.5K
Change To Inventory169K112K(465K)730K839.5K881.5K
Investments(70M)70M(57.1M)(25.9M)(23.3M)(22.2M)
Change In Cash(47.5M)41.8M(106.5M)6.1M5.5M5.8M
Stock Based Compensation4.9M7.3M9.0M9.5M11.0M11.5M
Free Cash Flow(50.7M)(33.2M)(52.7M)(46.5M)(41.9M)(44.0M)
Change In Working Capital(5.8M)2.3M(3.3M)1.2M1.1M1.2M
Begin Period Cash Flow119.8M72.3M114.1M7.6M8.8M8.3M
Total Cashflows From Investing Activities(384K)(70M)70M(57.1M)(51.4M)(48.8M)
Other Cashflows From Financing Activities48.3M5.1M458K(2.2M)(2.0M)(1.9M)
Depreciation97K93K89K92K105.8K67.1K
Capital Expenditures97K0.0272K112K128.8K146.9K
Total Cash From Operating Activities(50.7M)(33.2M)(52.5M)(46.4M)(41.8M)(43.9M)
Change To Account Receivables(112K)465K(730K)(2.6M)(2.4M)(2.3M)
Change To Operating Activities(735K)(3.8M)1.5M(1.6M)(1.4M)(1.5M)
Net Income(50.0M)(42.9M)(58.4M)(59.7M)(53.7M)(56.4M)
Total Cash From Financing Activities73.2M5.1M3.1M47.8M43.0M37.2M
End Period Cash Flow72.3M114.1M7.6M13.8M12.4M11.8M
Other Cashflows From Investing Activities29K(70M)70M(86.1M)(77.5M)(73.6M)
Change To Netincome633K993K4.7M7.3M8.4M8.8M
Change To Liabilities3.5M(2.1M)637K(907K)(816.3K)(775.5K)
Other Non Cash Items5.5M7.3M44K2.4M2.8M2.9M
Issuance Of Capital Stock24.9M0.02.6M(14K)(12.6K)(12.0K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.